All Posts

The Boye Lab

Boye lab research was featured in a recent FFB video.

Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the establishment of a research collaboration with the University of Florida and the University of Pennsylvania to develop a gene therapy for the treatment of a rare genetic disease that causes childhood blindness. Leber congenital amaurosis type 1 (LCA-1)…

Visitors like little Robert motivate us to develop cures for blindness

We were so happy to host Janice, Hugh, and Robert in our lab this month. They came all the way from Australia to learn more about our work on GUCY2D-LCA1. Despite their intense jet lag, mom and dad soaked up our description of phototransduction and Robert got to enjoy the ‘spinny…

Hello world!

Welcome to UF Health WebServices Sites. This is your first post. Edit or delete it, then start managing your website!…

The Boye lab grows by two!

The team is happy to welcome its two newest members. In August, postdoctoral associate Shreyasi Choudhury, Ph.D. and laboratory assistant Tyler McCullough, M.S. joined the group. They bring with them valuable experience in vision research and have already proven to be integral parts of our operation. Welcome Shreyasi and Tyler!…

The Boye Lab celebrates our newest Ph.D.

Congratulations Dr. Miranda Scalabrino for successfully completing your dissertation research on developing gene therapies for ON bipolar- mediated disease. You were a joy to have in the lab and we wish you all the best in your future endeavors. May this be the first of many fun graduation ceremonies!…

Examining advances in AAV vector for retinal gene therapy

Much work is being done with Adeno-associated virus (AAV) vectors for application in retinal gene therapy, with modifications being made to the capsid and genome of the vector to generate novel variants with unique transduction profiles, according to Shannon Boye, PhD…

UF Health researcher receives grant to combat severe form of childhood blindness

It’s usually in the first few months that parents of newborns with Leber congenital amaurosis realize something is wrong. The babies fail to focus on their parents’ faces, may be abnormally sensitive to light or have unusual eye movements. Parents then receive the devastating diagnosis: severe, permanent visual impairment.